Resona Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Sell
426,648
-37,477
-8% -$2.04M 0.09% 212
2026
Q1
$29.1M Buy
464,125
+9,180
+2% +$734K 0.15% 128
2025
Q4
$43.4M Sell
454,945
-15,983
-3% -$1.57M 0.21% 92
2025
Q3
$45.9M Sell
470,928
-23,169
-5% -$2.4M 0.22% 93
2025
Q2
$53M Buy
494,097
+24,919
+5% +$2.52M 0.26% 73
2025
Q1
$47.2M Buy
469,178
+34,240
+8% +$3.45M 0.27% 75
2024
Q4
$38.9M Sell
434,938
-8,687
-2% -$765K 0.23% 82
2024
Q3
$37.1M Sell
443,625
-7,660
-2% -$604K 0.22% 93
2024
Q2
$34.8M Sell
451,285
-24,675
-5% -$1.81M 0.21% 97
2024
Q1
$32.6M Buy
+475,960
New +$30.6M 0.19% 108

Other funds holding BSX

Resona Asset Management's BSX Position: Q2 2026 in Review

Resona Asset Management reduced its Boston Scientific (BSX) stake by 8.1% in Q2 2026, selling an estimated $2.04M and leaving 426,648 shares worth $18.3M. The position accounts for 0.09% of the portfolio, ranked #212.

Resona Asset Management first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $53M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Resona Asset Management held 426,648 shares of Boston Scientific worth $18.3M as of Q2 2026.
  • Resona Asset Management sold 37,477 Boston Scientific shares in Q2 2026, an estimated $2.04M.
  • Boston Scientific made up 0.09% of Resona Asset Management's portfolio in Q2 2026, its #212 holding.
  • Resona Asset Management first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's Boston Scientific position peaked at $53M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.